Introduction 2 0
In December 2019, a novel coronavirus, since named severe acute respiratory 2 1 syndrome coronavirus 2 (SARS-Cov-2), emerged in Wuhan, Hubei Province, China [1] , 2 2 causing an acute febrile illness with acute respiratory distress syndrome (ARDS), disease . [2] [3] [4] The type of pneumonia caused by the 2019 novel 2 5 coronavirus (2019-nCoV, equated with SARS-CoV-2) is a highly infectious disease, concern on January 30, 2020. [5] As of February 20, 2020, a total of 74679 clinically 2 8 diagnosed and laboratory confirmed cases had been reported in China, including 2122 2 9
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The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10. 1101/2020.02.21.20026187 doi: medRxiv preprint 1 qRT-PCR assay was performed using a 2019-nCoV nucleic acid detection kit 2 according to the manufacturer's protocol (Shanghai ZJ Bio-Tech Co Ltd). A cycle 3 threshold value (Ct-value) less than 37 was defined as a positive test result, and a 4 Ct-value of 40 or more was defined as a negative test. These diagnostic criteria were 5 based on the recommendation by the national institute for viral disease control and 6 Prevention (China) (http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html). A 7 medium load, defined as a Ct-value of 37 to less than 40, required confirmation by 8 retesting. All analyses were performed using SPSS 22.0. Continuous variables were The study population included 52 hospitalized patients suspected of having 1 9 COVID-19. The average age was 57.3 years (SD, 12.5; range, , and 27 2 0 (51.9%) were men. All patients received qRT-PCR assays in both throat swabs and 2 1 sputum specimens. (Table 1) 2 2 2 3
Comparison of throat swabs and sputum specimens 2 4
The viral nucleic acid by qRT-PCR showed that 23 cases (44.2%) of throat swabs 2 5 were positive while 29 cases (55.8%) were negative, and 40 cases (76.9%) of sputum 2 6 specimens were positive while 12 cases (23.1%) were negative ( Figure 1 ). The positive rate of sputum specimens was almost 2-fold that of throat swabs.
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Most of the patients (51.9%) had the same results of qRT-PCR assay on throat 2 9 swabs and sputum specimens, 36.5% with both positive and 15.4 % with both 3 0 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10. 1101 /2020 negative. However, quite a few patients (40.4%) showed positive sputum specimens 1 and negative throat swabs, while only a tiny minority of patients (7.7%) showed 2 negative sputum specimens and positive throat swabs. The findings showed that 3 positive rates displayed a significant statistical difference (P=0.001) between throat 4 swabs and sputum specimens. (Table 2) 5 6 Discussion 7 Adequate specimen collection is important for the diagnosis of respiratory viral 8 infections. [8] At present, the sample collection for viral nucleic acid detection of 9 suspected patients with COVID-19 is mostly upper respiratory tract samples (mainly 1 0 throat swabs). [10] The collection of throat swabs is not standardized and it is easy to 1 1 miss the diagnosis. The collection process is extremely risky for medical staff. Sputum is representative of the lower respiratory tract but is rarely used for viral 1 3
testing. The aim of this study was to compare the detection rates of 2019-nCoV RNA 1 4 from throat swabs and sputum specimens using the qRT-PCR assay. In our research, most of the patients were middle-aged and elderly men, which 1 6 was similar to previous studies. [3, 4] Paired specimens of throat swabs and sputum were 1 7 obtained from 52 subjects. The positive rates of 2019-nCoV from sputum specimens 1 8 and throat swabs were 76.9% and 44.2%, respectively. The present study found that 1 9 the overall positive rate from sputum specimens in adults was significantly higher 2 0 than that from throat swabs using qRT-PCR assay. This finding was consistent with 2 1 the result of a previous study that sputum showed a significantly higher positive rate 2 2 than nasopharyngeal swabs in detecting respiratory viruses. [8] Falsey et al [11] also 2 3 proved that sputum samples showed higher diagnostic yields than nose-throat swabs 2 4 in adults.
5
The detection rate of 2019-nCoV from sputum samples was higher than that 2 6 from throat swabs, which may be related to novel coronavirus's main invasion and were increasingly recognized as the cause of lower respiratory tract infections. [8] In 3 0 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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It should be noted that the high viscosity of sputum can make it difficult to 5 extract nucleic acid. Therefore, pre-treatment of sputum samples is required, but 6 currently no standardized pre-treatment procedure is available for virus detection. In 7 our study, acetylcysteine was used for the digestion of sputum, which may cause 8 substantial loss of RNA due to the washing and pipetting steps in the procedures. 9 Therefore, thoroughly mixing and homogenization of sputum samples might be 1 0 important factors to obtain reliable test results. [8] 1 1
This study has several limitations. First, only 52 patients with suspected 1 2 COVID-19 were included, and further studies were needed to investigate the all patients with COVID-19 produce sputum, especially elderly patients. Therefore, if 1 8 a sputum sample is available, it might be a rather reliable specimen for nucleic acid 1 9 detection of 2019-nCoV.
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In conclusion, the detection rates of 2019-nCoV from sputum specimens are 2 1 significantly higher than those from throat swabs using the qRT-PCR assay. We 2 2 suggest that sputum would benefit for the detection of novel coronavirus in patients author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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